.jpg)
Data are from a cross-sectional, naturalistic, multicenter study conducted in 15 French public hospitals in a region of southeastern France during a 1-week period in 2008.
Patients were outpatients with a diagnosis of schizophrenia or schizoaffective disorder according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria.
Insight was measured by the psychiatrist using the SUMD.
The following 3 global insight dimensions were used:
- Having a mental disorder
- Effects of medication
- Consequences of the mental disorder
Each of these dimensions is rated on a 5-point rating scale: 0= not applicable, 1= aware, 3= somewhat aware/unaware, and 5= severely unaware. A score ≥3 was indicative of a poor individual level of insight.
Nonadherent patients presented a lower level of insight than adherent patients for the 3 dimensions of the SUMD (P<0.001).
Reference:
Dassa D, Boyer L, Benoit M, Bourcet S, Raymondet P, Bottai T. Factors associated with medication non-adherence in patients suffering from schizophrenia: a cross-sectional study in a universal coverage health-care system. Aust N Z J Psychiatry. 2010; 44(10): 921-928.